Chiesi

Tiny green sprout growing from soil
Biotech

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Chiesi is shelling out $115 million upfront to develop and commercialize ABO-101, a gene therapy for primary hyperoxaluria type 1.
Darren Incorvaia Oct 6, 2025 7:00am
photo of a life preserver in open water

Chiesi buys into Gossamer's Winrevair rival

May 6, 2024 10:28am